Honey purified 1.5g/5ml / Glycerol 630mg/5ml oral solution
Official documents, adverse reaction reporting, and safety monitoring
Report a side effect
Submit a Yellow Card report to the MHRA
Official medicine documents
Safety monitoring data
Yellow Card reports
The MHRA Yellow Card scheme collects reports of suspected side effects from healthcare professionals and patients. View the Drug Analysis Profile (iDAP) for real-world adverse reaction data.
View Drug Analysis Profile
Browse all Drug Analysis Profiles A–Z
Browse all iDAP reports
Interactive Drug Analysis Profiles for all medicines
Report a side effect
Submit a Yellow Card report to the MHRA
Data from the MHRA Yellow Card scheme. A reported reaction does not necessarily mean the medicine caused it. Contains public sector information licensed under the Open Government Licence v3.0.
EudraVigilance
The European Medicines Agency (EMA) collects suspected adverse reaction reports from across the EU/EEA through the EudraVigilance system. Search for safety data on this medicine.
Search EudraVigilance database
Browse substances A–Z in the European adverse reaction database
About EudraVigilance
Learn about EU pharmacovigilance and safety monitoring
EudraVigilance data is published by the European Medicines Agency (EMA). A suspected adverse reaction is not necessarily caused by the medicine.
1 branded products available
Therapeutically similar medicines
Similarity is based on WHO Anatomical Therapeutic Chemical (ATC) classification and on a factual NHS dm+d therapeutic-grouping code prefix. Source data: NHS dm+d via TRUD (OGL v3.0), WHO ATC/DDD Index.
NHS prescribing volume and spending trends
Check stock at pharmacies and supply information
Pharmacy stock checkers
Search for this medicine at major UK pharmacy chains. These links open the retailer's own website — results depend on their current online catalogue.
Supply & safety information
Official UK regulator monitoring and safety alerts
Pharmacy links redirect to the retailer's own search and do not represent real-time stock levels. Shortage and safety information sourced from MHRA drug safety updates (gov.uk, Crown Copyright under OGL v3.0).
Codes for healthcare professionals and prescribing systems
These codes are used by healthcare IT systems and prescribers to identify this medicine.
NHS UK identifiers
SNOMED CT and dm+d codes from NHS TRUD (Technology Reference data Update Distribution), licensed under the Open Government Licence v3.0. BNF code shown is the factual mapping value distributed by NHS Business Services Authority (NHSBSA) in the dm+d supplementary file under OGL v3.0; it is not affiliated with, nor licensed from, the publishers of the British National Formulary.
Active and completed clinical studies from ClinicalTrials.gov
Source: ClinicalTrials.gov, a database of the U.S. National Library of Medicine (NLM), National Institutes of Health (NIH). Data accessed via ClinicalTrials.gov API v2. Trial information is provided for research purposes and does not constitute medical advice.
Academic studies and reviews for this medicine's active substance
Showing the 50 most relevant studies.
Reviews & meta-analyses: 10 · 1969–2026
Showing the 50 most relevant studies, sorted by most relevant.
German Zapata‐Hernández, Martina Gajardo‐Rojas, Matías Calderón‐Seguel, et al.
Global Change Biology, 2024
- Pesticides
- Beekeeping
- Bees
Guntari P, Junaida A, Eny P, et al.
2025
BackgroundFructose-containing sugars are widely consumed, yet their metabolic effects remain debated.ObjectiveThis meta-analysis aimed to evaluate the impact of different fructose-containing sugars on glycaemic control, lipid profiles, and uric acid levels in adults.MethodsA total of 17 study codes from seven clinical trials were included, with intervention durations ranging from 7 h to 49 days. Interventions were classified as fructose, fructose-glucose mixtures (F/G), honey, or sucrose. Comparators varied and included unsweetened beverages, artificial sweeteners, and habitual diets. Meta-analyses using random-effects models assessed outcomes including fasting blood glucose (FBG), serum insulin, total cholesterol (TC), low-density lipoprotein cholesterol (LDL-c), very low-density lipoprotein cholesterol (VLDL-c), and uric acid. Effect sizes were reported as Hedges' g.ResultsFructose-glucose mixtures intake significantly increased FBG (Hedges' g = 0.474, P = 0.002) and serum insulin (Hedges' g = 0.592, P P = 0.006). Fructose and sucrose alone did not affect TC, but their combined intake resulted in a significant increase (Hedges' g = 0.412, P = 0.009). No significant changes were observed in LDL-c, VLDL-c, or pooled metabolic outcomes. Fructose intake was strongly associated with increased uric acid (Hedges' g = 1.628, P g = 0.550, P = 0.028).ConclusionThe short-term consumption of added sugars - fructose, sucrose, and F/G mixtures - had minimal effects on FBG, insulin, triglycerides (TG), non-esterified fatty acids (NEFAs), high-density lipoprotein cholesterol (HDL-c), and VLDL-c. However, significant increases in TC and LDL-c were observed, particularly with fructose and sucrose, indicating adverse effects on lipid metabolism. Some fructose interventions, especially those using high-fructose corn syrup, also showed marked increases in uric acid. While acute metabolic changes were limited, these findings suggest that regular intake of added sugars may elevate cardiometabolic risk. Long-term studies are warranted to clarify chronic effects and inform dietary guidelines.
Abstract licence: CC BY
Lucie Kešnerová, Ruben A. Mars, Kirsten Ellegaard, et al.
PLoS Biology, 2017
- Gastrointestinal Microbiome
- Bacteria
- Bees
Xiangdong Zhao, Susanne Procopio, Thomas Becker
Journal of Food Science and Technology, 2015
Miguel A. Cerqueira, Bartolomeu Warlene Silva de Souza, J. A. Teixeira, et al.
Food Hydrocolloids, 2011
Eva Forsgren, Tobias C. Olofsson, Alejandra Vásquez, et al.
Apidologie, 2009
Wenfu Mao, Mary A. Schuler, May R. Berenbaum
Proceedings of the National Academy of Sciences, 2013
- Bees
- Chromatography, High Pressure Liquid
- Coumaphos
Md. Ibrahim Khalil, Mohammed Moniruzzaman, Laïd Boukraâ, et al.
Molecules, 2012
- Algeria
- Antioxidants
- Ascorbic Acid
Mohammed Moniruzzaman, Md. Ibrahim Khalil, Siti Amrah Sulaiman, et al.
BMC Complementary and Alternative Medicine, 2013
- Acacia
- Bees
- Fabaceae
Liliana Luca, Daniela Pauliuc, Mircea Oroian
Food Chemistry X, 2024
Sources: aggregated from Europe PMC (EMBL-EBI), OpenAlex, Crossref, PubMed and other open scholarly databases. Retracted articles are excluded. Study information is provided for research purposes and does not constitute medical advice.
Scientific data (pharmacology, interactions, ADME) is not yet available for this medicine. Clinical sections are sourced from the NHS dm+d database.